Literature DB >> 18075986

[Immune factors or depression? Fatigue correlates in Parkinson's disease].

Z Katsarou1, S Bostantjopoulou, O Hatzizisi, E Giza, A Soler-Cardona, G Kyriazis.   

Abstract

INTRODUCTION: Fatigue is a frequent symptom in Parkinson disease (PD), but its pathogenesis remains obscure. Fatigue may be influenced by depression and motor disability, but immunological factors have been also implicated. The purpose of the study was to assess fatigue in PD patients in relation to depression and various immunological factors. SUBJECTS AND METHODS: Forty PD patients and 26 normal matched controls were studied. Fatigue was assessed by the Fatigue Severity Scale (FSS). The Beck Depression Inventory (BDI) was employed for depression screening. The following immunological factors were estimated: a) T- and B-lymphocytes, T-lymphocyte subsets (helper/suppressor cells) as well as natural killer cells (NK); b) circulating levels of interleukins IL-1alpha, IL-1beta, IL-6, IL-1 receptor antagonist (IL-1Ra) and tumor necrosis factor-alpha.
RESULTS: FSS mean score was higher in PD patients compared to controls (p < 0.01). Significant differences between patients and controls were found in the following immunological parameters. In PD patients: a) mean percentage of NK cells was higher, p < 0.01); b) IL-1beta levels were significantly increased (p < 0.01) and IL-1Ra levels were decreased (p < 0.001). FSS correlated significantly to BDI (p < 0.008). Circulating Il-1Ra levels correlated to fatigue severity (p < 0.01), but after exclusion of depressed PD subjects this correlation significance level dropped to p = 0.055.
CONCLUSIONS: Our results indicate that fatigue is a common non motor symptom in PD. Immunological differences between PD patients and controls were observed in percentages of NK cells, IL-1beta and IL-1Ra blood levels. Fatigue correlated to depression and IL-Ra levels. However after exclusion of depressed subjects IL-1Ra levels showed only a tendency to significance, leaving depression as the principle correlate of fatigue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18075986

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  16 in total

Review 1.  Immune system responses in Parkinson's disease: Early and dynamic.

Authors:  Malú G Tansey; Marina Romero-Ramos
Journal:  Eur J Neurosci       Date:  2018-12-10       Impact factor: 3.386

Review 2.  Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?

Authors:  Marina Romero-Ramos; Marianne von Euler Chelpin; Vanesa Sanchez-Guajardo
Journal:  Hum Vaccin Immunother       Date:  2014-03-26       Impact factor: 3.452

3.  The Parkinson fatigue scale: an evaluation of its validity and reliability in Greek Parkinson's disease patients.

Authors:  Ioannis E Dagklis; Efthymia Tsantaki; Dimitrios Kazis; Varvara Theodoridou; Sotirios Papagiannopoulos; Dimitrios Ntantos; Sevasti Bostantjopoulou
Journal:  Neurol Sci       Date:  2019-01-08       Impact factor: 3.307

4.  Targeted versus chrono-targeted chemotherapy for inhaled chemotherapy in non-small cell lung cancer.

Authors:  Paul Zarogoulidis; Kaid Darwiche; George Kalamaras; Haidong Huang; Wolfgang Hohenforst-Schmidt; Konstantinos Zarogoulidis
Journal:  Transl Lung Cancer Res       Date:  2013-02

5.  Reduced Activated T Lymphocytes (CD4+CD25+) and Plasma Levels of Cytokines in Parkinson's Disease.

Authors:  Natalia Pessoa Rocha; Frankcinéia Assis; Paula Luciana Scalzo; Érica Leandro Marciano Vieira; Izabela Guimarães Barbosa; Mariana Soares de Souza; Paulo Pereira Christo; Helton José Reis; Antonio Lucio Teixeira
Journal:  Mol Neurobiol       Date:  2017-02-07       Impact factor: 5.590

6.  Perfusion Imaging of Fatigue and Time-on-Task Effects in Patients With Parkinson's Disease.

Authors:  Wanting Liu; Jianghong Liu; Rupal Bhavsar; Tianxin Mao; Eugenia Mamikonyan; David Raizen; John A Detre; Daniel Weintraub; Hengyi Rao
Journal:  Front Aging Neurosci       Date:  2022-06-10       Impact factor: 5.702

Review 7.  Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology.

Authors:  John D Salamone; Samantha E Yohn; Laura López-Cruz; Noemí San Miguel; Mercè Correa
Journal:  Brain       Date:  2016-05       Impact factor: 13.501

8.  Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task.

Authors:  Eric J Nunes; Patrick A Randall; Alexavier Estrada; Brian Epling; Evan E Hart; Christie A Lee; Younis Baqi; Christa E Müller; Mercè Correa; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2013-10-18       Impact factor: 4.530

Review 9.  Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies.

Authors:  Natália Pessoa Rocha; Aline Silva de Miranda; Antônio Lúcio Teixeira
Journal:  Biomed Res Int       Date:  2015-07-29       Impact factor: 3.411

10.  Validity and reliability of the FSS in Greek MS patients.

Authors:  Daphne Bakalidou; Emmanouil K Skordilis; Sotirios Giannopoulos; Elefterios Stamboulis; Konstantinos Voumvourakis
Journal:  Springerplus       Date:  2013-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.